Presentation
Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).
Journal of Clinical Oncology
(2019)
Disciplines
Publication Date
May 20, 2019
DOI
10.1200/jco.2019.37.15_suppl.2555
Citation Information
Miguel Angel Villalona-Calero, John Paul Diaz, Zuanel Diaz, Wenrui Duan, et al.. "Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM)." Journal of Clinical Oncology Vol. 37 (2019) p. 2555 - 2555 Available at: http://works.bepress.com/sara-garrido/14/